How is Polpharma Biologics innovating through the integration of advanced cell line development capabilities to help shape the future of healthcare?

Published: 22.07.2020

 

In Pharma’s Almanac read more about integration of Bioceros’ capabilities into Polpharma Biologics. This change made Polpharma Biologics a truly integrated CDMO, offering the complete spectrum of services from discovery to commercial supply.

 

 

“Polpharma Biologics is now joining the ranks of leading CDMOs with a world-class offering to help partners take their product from concept to commercial supply”

 

 

written by: Polpharma Biologics

Let’s collaborate and deliver quality biosimilars together.

Get in touch for more information.